FDA Warns Against Supplements for Erectile Dysfunction
By News Staff
7/18/2006
The products contain some ingredients or analogues of ingredients in drugs the FDA already has approved -- such as sildenafil, the active ingredient in Viagra, or vardenafil, the active ingredient in Levitra -- but the product labels of the so-called supplements do not list these ingredients, says the news release.
Sign Up for FDA E-Mail Alerts
The news release advises consumers to consult a health care professional before purchasing a product to treat ED.
FDA Panel Recommends Acetaminophen Restrictions
ACIP Gives Thumbs-up to New Antiviral Recs
CDC Reinstates Hib Booster for 12- to 15-month-olds
Committee Recommends A1c Testing for Diabetes Diagnosis
CDC Urges Health Workers to Avoid H1N1 Infection
WHO Declares Pandemic, But Little Else Changes
AAFP Posts New Pregnancy-related Clinical Services Recommendations
Thyroid Drug Linked to Liver Injury, FDA Warns
IOM Updates Guidelines for Weight Gain in Pregnancy
Manufacturers to Begin Work on H1N1 Vaccine
Role of FPs in Prenatal Care Declining Even in Rural Areas
CDC Considering Early Start to Flu Vaccinations
CDC Urges Docs Not to Hoard Hep B Vaccine Doses
H1N1 Flu: CDC Updates Antiviral Guidance
FDA Requiring Label Changes for Botox Products
MedWatch E-List Keeps Clinicians Informed
(7/28/2005)
Additional Resources
Recent FDA Warning Letter to Herbal Remedies Web Site
FDA 2004 Talk Paper on Actra-Rx








